Plain-English translation of NCT07016971 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing —a plant-based supplement containing cannabinoids—to see if it can safely relieve persistent nerve pain and numbness that some patients experience after completing chemotherapy for stomach, pancreas, colon, or other digestive cancers. The medication is based on laboratory research showing these plant compounds reduced nerve pain in animal studies. This small pilot study will evaluate whether the treatment is safe and whether it actually helps real patients.
Many cancer survivors struggle with nerve pain and numbness after chemotherapy that current medications don't adequately treat or that cause bothersome side effects. This trial exists to explore whether this plant-based treatment might offer a new option for patients who need relief.
You likely qualify if…
You likely don't qualify if…
You will take the medication by placing it under your tongue twice daily for 12 weeks. You'll start with a smaller dose during the first week, then increase to the full dose for the remaining 11 weeks. The study is organized into three 4-week cycles with visits to assess how you're doing. You'll receive weekly phone calls to check on your safety and any side effects, and one final phone call one month after finishing the medication. Throughout the study, researchers will ask you about your nerve pain, physical function, mood, and how well you're tolerating the treatment.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States